The Science: It was developed after researchers discovered its sexual arousal effects and was approved by the FDA in 2019 for treating hypoactive sexual desire disorder (HSDD) in premenopausal women
This may give mazdutide broader metabolic and weight-loss effects
Digestive Discomfort Other gastrointestinal symptoms such as diarrhea, constipation, and abdominal pain usually develop within the first few days after injection
Wegovy FDA-approved specifically for chronic weight management
This question concerns many patients considering GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) for obesity management
THERE'S A STORY that many people tell themselves about aging, and it goes something like this: As they get older, their physical health span declines precipitously when approaching the final decades of life